Mark Crossley, Indivior CEO
Indivior snaps up Narcan owner for $145M upfront, with an eye on next-gen nasal spray
The opioid epidemic, which kills more than 100,000 people every year in the US, is big business, even when it comes to reversing the effects …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
